A 1934 discovery remains a cornerstone of medicine, despite its complex and toxic history.
In short: Discovered in 1934, chloroquine revolutionized malaria treatment before finding a second life in managing autoimmune conditions like lupus and rheumatoid arthritis. Yet, this synthetic quinoline derivative carries significant risks, including irreversible retinal damage and complex drug interactions, making its clinical application a delicate balance of efficacy and safety.
Chloroquine, a synthetic quinoline derivative, was first discovered in 1934 by Hans Andersag and entered medical practice during the 1940s. Its primary historical utility lies in treating malaria, where it targets the asexual life cycle of parasites within red blood cells. While it remains on the World Health Organization's List of Essential Medicines, its effectiveness has been severely compromised by the widespread emergence of resistant parasite strains, particularly in Plasmodium falciparum. Consequently, modern clinical guidelines often favor combination therapies over chloroquine monotherapy.
Beyond its antimalarial roots, the drug is utilized for its immune-suppressing properties in treating inflammatory rheumatic diseases such as rheumatoid arthritis and lupus erythematosus. Despite these benefits, the drug's safety profile is marked by significant concerns. Long-term administration is associated with chloroquine retinopathy, a form of irreversible retinal damage. Other potential adverse effects range from mild symptoms like nausea and headache to more severe complications, including cardiomyopathy, conduction disturbances, and various blood disorders like pancytopenia.
The chemical complexity of chloroquine, identified by the molecular formula C18H26ClN3, contributes to its intricate interactions with other substances. For instance, antacids can impede its absorption, while medications like cimetidine may inhibit its metabolism, leading to potentially toxic accumulation in the body. Furthermore, the drug exhibits notable demographic variations in side effects; for example, chloroquine-induced itching is reported by approximately 70% of black Africans, a phenomenon that often hinders treatment compliance. Given these factors, careful monitoring is essential, particularly for elderly patients or those with impaired kidney function, as the drug is cleared renally.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Chloroquine
- Also: Chloroquine | Description, Uses, & Side Effects | Britannica
- Also: Chloroquine
To cite this card, link to https://intellectplus.co.uk/app/health-chloroquine.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Drugs and medication · More in Health · Latest · A–Z · All topics
